MedPath

To compare lignocaine alone and in combination with dexmedetomidine for intravenous regional anaesthesia for upper limb surgery.

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2019/05/018918
Lead Sponsor
Jln Medical College ajmer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Age between 20 to 55 years, of either sex.

2.Body weight 35 to 80 kg.

3.Patients belonging to ASA Class I and II.

4. Patients undergoing upper limb surgeries of duration less than 45 minutes.

5.Patient free from any associated acute or chronic systemic illness.

Exclusion Criteria

1. Patients with contraindications to tourniquet application like sickle cell anemia, cellulitis, sepsis, open wound in that extremity, etc.

2. Patients hypersensitive to lignocaine

3. Patient not willing for IVRA

4. Patient already on analgesics (opioids, NSAIDS)

5. Patients receiving beta blockers or cardiac drugs.

6. History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit, thyroid disorder.

7. Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above).

8. Inadequate block necessitating institution of general anaesthesia for continuation of surgical procedure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality and duration of post-operative analgesiaTimepoint: duration of study is around 1 year
Secondary Outcome Measures
NameTimeMethod
1.Torniquet pain. <br/ ><br>2. Need for analgesic supplements <br/ ><br>3. Post operative sedation <br/ ><br>4. Adverse effects including nausea, vomiting, bradycardia, hypotension, desaturation and others, if anyTimepoint: Duration of study is around 1 year
© Copyright 2025. All Rights Reserved by MedPath